tiprankstipranks
Advertisement
Advertisement

LAB Stock Latest News

Standard BioTools Grants RSUs to Chief Business Officer
Company AnnouncementsStandard BioTools Grants RSUs to Chief Business Officer
1h ago
8K
LAB
Standard BioTools Adopts New Executive Severance Protection Plans
PremiumCompany Announcements
Standard BioTools Adopts New Executive Severance Protection Plans
6d ago
8K
LAB
Standard Biotools Faces Nasdaq Delisting Risk After Prolonged Sub-$1 Share Price
PremiumCompany Announcements
Standard Biotools Faces Nasdaq Delisting Risk After Prolonged Sub-$1 Share Price
27d ago
LAB
Standard BioTools Highlights Improved Q1 2026 Results, Outlook
PremiumCompany Announcements
Standard BioTools Highlights Improved Q1 2026 Results, Outlook
29d ago
8K
LAB
Is LAB a Buy, Before Earnings?
PremiumPre-Earnings
Is LAB a Buy, Before Earnings?
1M ago
LAB
Standard BioTools Receives Nasdaq Minimum Bid Price Deficiency Notice
PremiumCompany AnnouncementsStandard BioTools Receives Nasdaq Minimum Bid Price Deficiency Notice
1M ago
8K
LAB
Standard BioTools: Neutral Stance Amid Revenue Contraction Risk and M&A-Dependent Growth Outlook
Premium
Ratings
Standard BioTools: Neutral Stance Amid Revenue Contraction Risk and M&A-Dependent Growth Outlook
3M ago
LAB
Standard BioTools Details SomaLogic Sale and Profitability Path
Premium
Company Announcements
Standard BioTools Details SomaLogic Sale and Profitability Path
3M ago
8K
LAB
Standard BioTools reports Q4 EPS 5c vs (9c) last year
PremiumThe Fly
Standard BioTools reports Q4 EPS 5c vs (9c) last year
3M ago
LAB
Standard BioTools sees FY26 revenue $80M-$85M, consensus $79.73M
PremiumThe Fly
Standard BioTools sees FY26 revenue $80M-$85M, consensus $79.73M
3M ago
LAB
Is LAB a Buy, Before Earnings?
PremiumPre-Earnings
Is LAB a Buy, Before Earnings?
3M ago
LAB
Standard BioTools Completes Major Proteomics Business Divestiture
PremiumCompany Announcements
Standard BioTools Completes Major Proteomics Business Divestiture
4M ago
8K
LAB
Standard BioTools completes sale of SomaLogic to Illumina
PremiumThe FlyStandard BioTools completes sale of SomaLogic to Illumina
4M ago
LAB
ILMN
Standard BioTools sees Q4 revenue from cont. ops. $24M, consensus $18.5M
Premium
The Fly
Standard BioTools sees Q4 revenue from cont. ops. $24M, consensus $18.5M
5M ago
LAB
Standard BioTools price target lowered to $1.35 from $1.55 at TD Cowen
Premium
The Fly
Standard BioTools price target lowered to $1.35 from $1.55 at TD Cowen
7M ago
LAB
Standard BioTools Inc. Reports Q3 2025 Financial Results
PremiumCompany Announcements
Standard BioTools Inc. Reports Q3 2025 Financial Results
7M ago
LAB
Cautious Hold Rating for Standard BioTools Amid Economic Challenges and Uncertain Strategic Outlook
PremiumRatings
Cautious Hold Rating for Standard BioTools Amid Economic Challenges and Uncertain Strategic Outlook
7M ago
LAB
Standard BioTools Implements Restructuring for Future Growth
PremiumCompany Announcements
Standard BioTools Implements Restructuring for Future Growth
7M ago
8K
LAB
LAB Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
LAB Upcoming Earnings Report: What to Expect?
7M ago
LAB
Standard BioTools Announces Workforce Reduction Plan
PremiumCompany AnnouncementsStandard BioTools Announces Workforce Reduction Plan
9M ago
8K
LAB
Standard BioTools Announces Strategic Restructuring Plan
Premium
Company Announcements
Standard BioTools Announces Strategic Restructuring Plan
9M ago
8K
LAB
Standard Biotools Inc. Faces Challenges in SomaScan Divestiture: Potential Risks and Strategic Imperatives
Premium
Company Announcements
Standard Biotools Inc. Faces Challenges in SomaScan Divestiture: Potential Risks and Strategic Imperatives
10M ago
LAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >